Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akebia Therapeutics

2.43
-0.1200-4.71%
Post-market: 2.42-0.0103-0.42%19:59 EDT
Volume:7.03M
Turnover:16.97M
Market Cap:638.21M
PE:-11.72
High:2.60
Open:2.60
Low:2.36
Close:2.55
Loading ...
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Aug 28, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 28, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]